All Stories

  1. Back to the Future: Repurposing Metformin, a Metabolically Active Drug, to Treat Mild-to-Moderate Ulcerative Colitis
  2. Diagnostic–Therapeutic Care Pathway in Chronic Constipation: AIGO (Italian Association of Gastroenterologists and Gastrointestinal Endoscopists) Position Paper
  3. Persistent Abdominal Pain in Patients with Inactive Inflammatory Bowel Disease: A Clinical Conundrum
  4. Repurposing metformin: another possible bullet to target cheaply ulcerative colitis
  5. Gut–Liver Axis, Microbiota, Bile Acids, and Immune Response in Pathogenesis of Primary Sclerosing Cholangitis: An Overview
  6. 24-hour colonic manometry can reveal exaggerated rectosigmoid junction (sphincter of O’Beirne) activity in severely constipated patients
  7. Ultrasound assessment of constipation: do not put the cart before the horse
  8. The Sweet Side of Constipation: Colonic Motor Dysfunction in Diabetes Mellitus
  9. Most prominent challenges in translational neuroscience and strategic solutions to bridge the gaps: Perspectives from an editorial board interrogation
  10. Constipation in Ulcerative Colitis: An Underestimated Problem
  11. Histological differentiation of inflammatory bowel disease from “diverticular colitis”: an actual possibility or the fog is still thick?
  12. Neurogastroenterology: The Cinderella among the ecological niches of gastroenterology?
  13. Transcutaneous Auricular Vagal Nerve Stimulation to Treat Chronic Constipation: Another Therapeutic Failure?
  14. Author's reply: Claudin-2 immunochemistry in IBD
  15. Diagnosing Ulcerative Colitis: Should We Go Beyond the Surface?
  16. Histological healing in IBD: Ready for prime time?
  17. Moving forward: may some of “functional” gut disorders be reclassified as enteric neuro-gliopathies?
  18. Claudin-2: A marker for a better evaluation of histological mucosal healing in inflammatory bowel diseases
  19. Colonic motility investigation by modern techniques: time to ‘reclaim’ the value of physiology?
  20. Mucosal Healing in Inflammatory Bowel Diseases: Still too Many Irons on the Fire
  21. The Diagnosis and Management of Chronic Constipation in Italy: Results from a Survey Conducted among Italian Gastroenterologists
  22. Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: a prospective, international st
  23. Defining Occasional Constipation: A Straitjacket?
  24. PhosphoLipidome Alteration Induced by Clostridioides difficile Toxin B in Enteric Glial Cells
  25. Editorial: Sonographic assessment of colonic content—A new tool for constipation?
  26. Targeting diarrhea-predominant irritable bowel syndrome: hopes or hypes?
  27. Treating colonic diverticula with rifaximin: a call to action
  28. An Unusually Rapid-Onset Portal Hypertension
  29. Pro-Inflammatory Cytokines Enhanced In Vitro Cytotoxic Activity of Clostridioides difficile Toxin B in Enteric Glial Cells: The Achilles Heel of Clostridioides difficile Infection?
  30. Intestinal ultrasound, an underutilized tool for assessing colonic motility
  31. Ten years of successful linaclotide treatment in a patient with intestinal pseudo-obstruction due to Ehlers-Danlos syndrome
  32. Letter: Abdominal pain in inflammatory bowel disease patients in remission—A look beyond psychosocial factors
  33. Letter: The importance of histological assessment—a further stride in STRIDE
  34. Relief from behind: enemas, the back door enforcement to help treating chronic constipation in adults
  35. Misinterpreting Diarrhea-Predominant Irritable Bowel Syndrome and Functional Diarrhea: Pathophysiological Highlights
  36. Role of the Alteration in Calcium Homeostasis in Cell Death Induced by Clostridioides difficile Toxin A and Toxin B
  37. Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis
  38. Inflammatory Bowel Diseases: Does One Histological Score Fit All?
  39. Pathology: One Score Fits All?
  40. Clostridioides difficile Toxin B Induced Senescence: A New Pathologic Player for Colorectal Cancer?
  41. Possible Role of Carbocysteine Syrup in the Deflation of Percutaneous Endoscopic Gastrostomy Balloons
  42. Considerations for laxatives in terms of their interactions with other drugs
  43. Exploring Pharmacological Treatments for Chronic Idiopathic Constipation in Adults: A Look Back to the Future
  44. Pharmacotherapeutic advances for chronic idiopathic constipation in adults
  45. Unexpected findings in a bright liver
  46. More than twenty years of medical treatment in a patient with esophageal achalasia
  47. Clostridioides difficile toxin B alone and with pro-inflammatory cytokines induces apoptosis in enteric glial cells by activating three different signalling pathways mediated by caspases, calpains and cathepsin B
  48. Irritable Bowel Syndrome: A Multifaceted World Still to Discover
  49. Translational Gap between Guidelines and Clinical Medicine: The Viewpoint of Italian General Practitioners in the Management of IBS
  50. Gluten Induces Subtle Histological Changes in Duodenal Mucosa of Patients with Non-Coeliac Gluten Sensitivity: A Multicentre Study
  51. Histological Features of Celiac-Disease-like Conditions Related to Immune Checkpoint Inhibitors Therapy: A Signal to Keep in Mind for Pathologists
  52. Neuromuscular Function Abnormalities
  53. Clostridioides difficile Infection in Patients with Inflammatory Bowel Disease May be Favoured by the Effects of Proinflammatory Cytokines on the Enteroglial Network
  54. The Management of Acute Colonic Diverticulitis in the COVID-19 Era: A Scoping Review
  55. Chronic Idiopathic Constipation in Adults: A Review on Current Guidelines and Emerging Treatment Options
  56. New pharmacologic treatments for idiopathic chronic constipation: a financial strain for strainers
  57. Dermatological Manifestations in Inflammatory Bowel Diseases
  58. 1907–2020: more than one century of colonic mass movements in humans
  59. Proinflammatory Cytokines: Possible Accomplices for the Systemic Effects of Clostridioides difficile Toxin B
  60. Abdominal Symptoms and Colonic Diverticula in Marfan’s Syndrome: A Clinical and Ultrasonographic Case Control Study
  61. The cytotoxic synergy betweenClostridioides difficiletoxin B and proinflammatory cytokines: an unholy alliance favoring the onset ofClostridioides difficileinfection and relapses
  62. Irritable Bowel Syndrome and Gluten-Related Disorders
  63. When physiology meets technology: redefining colonic mass movements
  64. Side Effects Associated with Probiotic Use in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  65. microRNA‐mRNA network model in patients with achalasia
  66. Plecanatide for the treatment of chronic idiopathic constipation in adult patients
  67. First translational consensus on terminology and definitions of colonic motility in animals and humans studied by manometric and other techniques
  68. Pneumococcal vaccination in celiac disease
  69. Prucalopride for the treatment of constipation: a view from 2015 and beyond
  70. Long-term treatment with linaclotide of intestinal pseudo-obstruction secondary to Ehlers-Danlos syndrome
  71. Different perception of chronic constipation between patients and gastroenterologists
  72. Effects of probiotic bacteria on mucosal polyamines levels in dogs with IBD and colonic polyps: a preliminary study
  73. Usefulness of Bisacodyl Testing on Therapeutic Outcomes in Refractory Constipation
  74. Effects of a probiotic (SLAB51™) on clinical and histologic variables and microbiota of cats with chronic constipation/megacolon: a pilot study
  75. Helicobacter pylori infection and occurrence of celiac disease in subjects HLA-DQ2/DQ8 positive: A prospective study
  76. Clostridium difficile-related postinfectious IBS: a case of enteroglial microbiological stalking and/or the solution of a conundrum?
  77. Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life Study
  78. Toward optimal processing of endoscopic submucosal dissection specimens
  79. Eosinophilia - associated basal plasmacytosis: an early and sensitive histologic feature of inflammatory bowel disease
  80. Histopathological findings of extra-ileal manifestations at initial diagnosis of Crohn’s disease-related ileitis
  81. The enteric nervous system in patients with calculous and acalculous gallbladder
  82. Intestinal metaplasia in Barrett's oesophagus: An essential factor to predict the risk of dysplasia and cancer development
  83. Letter: histological assessment of disease activity in ulcerative colitis - the problem of score evaluation and validation
  84. Assessing mucosal healing in ulcerative colitis: the simpler, the better…
  85. Editorial: enhancing gluten digestion in the stomach - a further help to minimise unintentional ingestion?
  86. Controlling defecation: to be (predator) or not to be (prey), that is the question…
  87. Severe Gastritis with DoubleHelicobacterspp. Infection Associated with Barrett's Esophagus in a Cheetah